Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease
Abstract Background: Interleukin-6 (IL-6) is implicated in the pathogenesis of coronary heart disease (CHD), and IL-6 expression has associated with reduced DNA methylation of its gene promoter. However, there are no data on IL-6 promoter methylation and the risk of CHD. Objective: To examine whether IL-6 promoter methylation measured in blood leukocyte DNA is associated with CHD risk. Methods: A total of 212 cases with CHD and 218 controls were enrolled. Methylation at two CpG sites in IL-6 promoter was measured by bisulfite pyrosequencing, and the mean IL-6 methylation was calculated by averaging the methylation measures of the two CpGs. Results: Mean methylation level in IL-6 promoter in CHD cases was significantly lower than that in controls (p = 0.023). Logistic regression analysis showed that IL-6 methylation was inversely associated with the risk of CHD. The odds ratios (ORs) of CHD for subjects in the second and first (lowest) tertile of IL-6 methylation were 1.87 (95% CI = 1.10‑3.20) and 2.01 (95% CI = 1.19-3.38) (ptrend = 0.013), respectively, compared to subjects in the third (highest) tertile. The IL-6 hypomethylation-related risk estimates tended to be stronger for acute myocardial infarction (ptrend = 0.006). CpG position-specific analysis showed that hypomethylation of position 1 conferred a more pronounced increase in CHD risk than that of position 2. Conclusion: These findings suggest that DNA hypomethylation of IL-6 promoter is associated with the increased risk for CHD, especially for acute myocardial infarction. The two distinct CpGs in IL-6 may contribute differently to the development of CHD.
Main Authors: | , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia - SBC
2016
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004100131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0066-782X2016004100131 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0066-782X20160041001312016-09-09Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart DiseaseZuo,Hong-PengGuo,Ying-YuChe,LinWu,Xian-Zheng Coronary Artery Disease Interleukin-6 DNA Methylation Epigenetic Repression Abstract Background: Interleukin-6 (IL-6) is implicated in the pathogenesis of coronary heart disease (CHD), and IL-6 expression has associated with reduced DNA methylation of its gene promoter. However, there are no data on IL-6 promoter methylation and the risk of CHD. Objective: To examine whether IL-6 promoter methylation measured in blood leukocyte DNA is associated with CHD risk. Methods: A total of 212 cases with CHD and 218 controls were enrolled. Methylation at two CpG sites in IL-6 promoter was measured by bisulfite pyrosequencing, and the mean IL-6 methylation was calculated by averaging the methylation measures of the two CpGs. Results: Mean methylation level in IL-6 promoter in CHD cases was significantly lower than that in controls (p = 0.023). Logistic regression analysis showed that IL-6 methylation was inversely associated with the risk of CHD. The odds ratios (ORs) of CHD for subjects in the second and first (lowest) tertile of IL-6 methylation were 1.87 (95% CI = 1.10‑3.20) and 2.01 (95% CI = 1.19-3.38) (ptrend = 0.013), respectively, compared to subjects in the third (highest) tertile. The IL-6 hypomethylation-related risk estimates tended to be stronger for acute myocardial infarction (ptrend = 0.006). CpG position-specific analysis showed that hypomethylation of position 1 conferred a more pronounced increase in CHD risk than that of position 2. Conclusion: These findings suggest that DNA hypomethylation of IL-6 promoter is associated with the increased risk for CHD, especially for acute myocardial infarction. The two distinct CpGs in IL-6 may contribute differently to the development of CHD.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.107 n.2 20162016-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004100131en10.5935/abc.20160124 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Zuo,Hong-Peng Guo,Ying-Yu Che,Lin Wu,Xian-Zheng |
spellingShingle |
Zuo,Hong-Peng Guo,Ying-Yu Che,Lin Wu,Xian-Zheng Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
author_facet |
Zuo,Hong-Peng Guo,Ying-Yu Che,Lin Wu,Xian-Zheng |
author_sort |
Zuo,Hong-Peng |
title |
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
title_short |
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
title_full |
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
title_fullStr |
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
title_full_unstemmed |
Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease |
title_sort |
hypomethylation of interleukin-6 promoter is associated with the risk of coronary heart disease |
description |
Abstract Background: Interleukin-6 (IL-6) is implicated in the pathogenesis of coronary heart disease (CHD), and IL-6 expression has associated with reduced DNA methylation of its gene promoter. However, there are no data on IL-6 promoter methylation and the risk of CHD. Objective: To examine whether IL-6 promoter methylation measured in blood leukocyte DNA is associated with CHD risk. Methods: A total of 212 cases with CHD and 218 controls were enrolled. Methylation at two CpG sites in IL-6 promoter was measured by bisulfite pyrosequencing, and the mean IL-6 methylation was calculated by averaging the methylation measures of the two CpGs. Results: Mean methylation level in IL-6 promoter in CHD cases was significantly lower than that in controls (p = 0.023). Logistic regression analysis showed that IL-6 methylation was inversely associated with the risk of CHD. The odds ratios (ORs) of CHD for subjects in the second and first (lowest) tertile of IL-6 methylation were 1.87 (95% CI = 1.10‑3.20) and 2.01 (95% CI = 1.19-3.38) (ptrend = 0.013), respectively, compared to subjects in the third (highest) tertile. The IL-6 hypomethylation-related risk estimates tended to be stronger for acute myocardial infarction (ptrend = 0.006). CpG position-specific analysis showed that hypomethylation of position 1 conferred a more pronounced increase in CHD risk than that of position 2. Conclusion: These findings suggest that DNA hypomethylation of IL-6 promoter is associated with the increased risk for CHD, especially for acute myocardial infarction. The two distinct CpGs in IL-6 may contribute differently to the development of CHD. |
publisher |
Sociedade Brasileira de Cardiologia - SBC |
publishDate |
2016 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016004100131 |
work_keys_str_mv |
AT zuohongpeng hypomethylationofinterleukin6promoterisassociatedwiththeriskofcoronaryheartdisease AT guoyingyu hypomethylationofinterleukin6promoterisassociatedwiththeriskofcoronaryheartdisease AT chelin hypomethylationofinterleukin6promoterisassociatedwiththeriskofcoronaryheartdisease AT wuxianzheng hypomethylationofinterleukin6promoterisassociatedwiththeriskofcoronaryheartdisease |
_version_ |
1756382000338436096 |